comparemela.com

Latest Breaking News On - Pharma science - Page 6 : comparemela.com

usfda: Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral suspension

Strides Pharma Science Ltd on Wednesday said its wholly-owned arm, Strides Pharma Global Pte. Ltd, Singapore, has received approval from the US health regulator for generic Mycophenolate Mofetil for oral suspension indicated in organ transplant patients to avoid rejection. The approval granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for oral suspension of strength 200 mg/ml, Strides Pharma Science said in a regulatory filing.

Share Market Highlights 2 August 2023: Sensex, Nifty fall over 1% amid global sentiment slump

Share Market Highlights 2 August 2023: Sensex, Nifty fall over 1% amid global sentiment slump
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Global Acetazolamide Market Projected to Reach $271 69 Million by 2028: Driven by Growing Incidence of Glaucoma and Innovation in Production

Strides Pharma Science shines on getting EIR from USFDA for Puducherry manufacturing facility

Strides Pharma Science is currently trading at Rs. 366.50, up by 7.10 points or 1.98% from its previous closing of Rs. 359.40 on the BSE. Strides Pharma Science The scrip opened at Rs. 364.85 and has touched a high and low of Rs. 375.00 and Rs. 363.30 respectively. So far 5955 shares were traded on

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.